B-cell activation is key to the pathogenesis of SS because the overactivation of B cells results in hypergammaglobulinemia and the production of the anti-ribonucleoprotein antibodies, anti-SSA/Ro, and anti-SSB/La antibodies [4,101,102] (Figure 3). The gene discussed is CALR; the disease is synovial sarcoma.